MARGARET AVERY: Open Payments
NPI 1306422191 · FORT WALTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$263 in 13 payments from 10 companies in 2025. Trend: 2023 $144 · 2024 $355 · 2025 $263
Food & beverage: $263
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| GENZYME CORPORATION | 1 | $32 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Dexcom, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: MOUNJARO, Veozah, KEVZARA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, TRINTELLIX, Ozempic, ACCRUFER.
Industry payments across FL — which companies pay providers there.
